SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 14th, 2020 • Cell Source, Inc. • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of July 29, 2020, between Cell Source, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANTCell Source, Inc. • August 14th, 2020 • Pharmaceutical preparations • Nevada
This Warrant is being issued pursuant to that certain Securities Purchase Agreement dated as of July 29, 2020 between the Holder and the Company (the “Securities Purchase Agreement”). In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement.
DUE JANUARY 29, 2021Cell Source, Inc. • August 14th, 2020 • Pharmaceutical preparations • Nevada
THIS 10.0% OID CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 10.0% OID Convertible Promissory Notes of Cell Source, Inc., a Nevada corporation (the “Company”), having its principal place of business at 57 West 57th Street, Suite 400, New York, New York 10019, designated as its 10.0% OID Convertible Promissory Notes due January 29, 2021 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
